Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about ESALY
Recent news which mentions ESALY
< Previous
1
2
3
4
Next >
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
September 28, 2022
Tickers
AGCO
BB
BIIB
CTAS
Tags
Penny Stocks
TCRT
Global
From
Benzinga
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
September 28, 2022
Tickers
BIIB
ESALY
Tags
BIIB
JP:4523
JP:NIK
From
MarketWatch
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
Biotech
Alzheimer's disease
BIIB
From
Benzinga
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
September 12, 2022
Tickers
ESALF
ESALY
MRK
Tags
Biotech
Large Cap
Health Care
From
Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
August 25, 2022
Tickers
ESALF
ESALY
LLY
RHHBF
Tags
Biotech
Large Cap
Health Care
From
Benzinga
Here's What Could Make This Beaten-Down Stock a Buy
August 19, 2022
Tickers
BIIB
ESALY
Tags
BIIB
Recent Press Releases
ESALY
From
Motley Fool
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
August 03, 2022
Tickers
ALNY
AMRN
ARQT
BMRN
Tags
VNDA
UTHR
SNY
From
Benzinga
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
August 03, 2022
Tickers
ESALF
ESALY
MRK
Tags
ESALF
General
News
From
Benzinga
Merck's Oncology Business Will Help It Crush the Bear Market
July 07, 2022
Tickers
AZN
ESALY
MRK
SGEN
Tags
ESALY
AZN
Recent Press Releases
From
Motley Fool
Is This Biotech Stock a Bad News Buy?
July 06, 2022
Tickers
BIIB
ESALY
Tags
Market News
ESALY
Recent Press Releases
From
Motley Fool
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
July 06, 2022
Tickers
AMTI
BIIB
ESALF
ESALY
Tags
FDA
Trading Ideas
AMTI
From
Benzinga
2 Safe Stocks to Buy in a Bear Market
May 21, 2022
Tickers
AZN
ESALY
ISRG
MDT
Tags
MRK
Market News
AZN
From
Motley Fool
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
May 10, 2022
Tickers
AGEN
ARWR
ATNX
AVGR
Tags
Earnings
ATNX
General
From
Benzinga
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
May 10, 2022
Tickers
BIIB
ESALF
ESALY
Tags
BIIB
Health Care
Alzheimer's disease
From
Benzinga
1 Reason to Buy Biogen Now, and 1 Reason to Wait
May 05, 2022
Tickers
BIIB
ESALY
SAGE
Tags
BIIB
Recent Press Releases
SAGE
From
Motley Fool
Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’
April 29, 2022
Tickers
ESALY
LLY
PFE
SPX
Tags
SPX
ESALY
DK:NOVO/B
From
MarketWatch
Is This Biotech Stock Worth the Trouble?
April 23, 2022
Tickers
BIIB
ESALY
LLY
SAGE
Tags
Recent Press Releases
BIIB
SAGE
From
Motley Fool
What This Regulatory Approval Could Mean for Merck
April 05, 2022
Tickers
ESALY
MRK
PFE
Tags
PFE
Recent Press Releases
ESALY
From
Motley Fool
The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study
April 01, 2022
Tickers
ABIO
ESALY
IBB
IMMP
Tags
General
IMMP
News
From
Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
March 22, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
ESALY
News
From
Benzinga
FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer
March 22, 2022
Tickers
ESALF
ESALY
MRK
Tags
Biotech
Health Care
Market News
From
Benzinga
Biogen, Eisai Amend Their Alzheimer's Drug Marketing Pact
March 15, 2022
Tickers
BIIB
ESALF
ESALY
Tags
ESALF
News
Briefs
From
Benzinga
The Daily Biotech Pulse: Biogen, Eisai Amend Aduhelm Agreement; Anaptys Acne Drug Flunks Midstage Study; Merck, AstraZeneca Discontinue Prostate Cancer Trial
March 15, 2022
Tickers
ALT
ANAB
ANIP
ATHX
Tags
Market News
Benzinga
Penny Stocks
From
Benzinga
The Daily Biotech Pulse: Ocugen Faces Regulatory Setback, vTv CEO Quits, Biogen-Eisai Make Headway With Second Alzheimer's Antibody Treatment In Japan
March 04, 2022
Tickers
BIIB
CEMI
ESALY
EYEN
Tags
BIIB
Biotech
Small Cap
From
Benzinga
Merck-Eisai's Keytruda/Lenvima Combo Scores Japanese Approval For Kidney Cancer Setting
February 25, 2022
Tickers
ESALF
ESALY
MRK
Tags
MRK
ESALF
Market News
From
Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Tickers
ALKS
AMGN
ARGX
BGNE
Tags
Market News
MRK
ARGX
From
Benzinga
Merck Snags Yet Another Indication for This Drug Combo
January 14, 2022
Tickers
ESALY
MRK
Tags
Recent Press Releases
MRK
ESALY
From
Motley Fool
CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply
January 12, 2022
Tickers
BIIB
ESALF
ESALY
LLY
Tags
BIIB
Health Care
Alzheimer's disease
From
Benzinga
Biogen Outlines Aduhelm's Confirmatory Trial Plans, Data Expected In 2026
December 16, 2021
Tickers
BIIB
ESALF
ESALY
Tags
Benzinga
FDA
Market News
From
Benzinga
Europe Approves Merck-Eisai's Keytruda/Lenvima Combo Therapy For Endometrial Carcinoma
November 29, 2021
Tickers
ESALF
ESALY
MRK
Tags
Benzinga
ESALF
MRK
From
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.